Israel’s Teva Pharmaceutical Industries Ltd., which has big operations in Irvine, posted a 9% rise in fourth-quarter profit on Tuesday, helped by further strong sales of multiple sclerosis treatment Copaxone as it prepares launches of generic drugs in 2006.
*For more on this story,
read the full Reuters article.
